Policy makers, the international community and the population in the prevention and treatment of diseases: case study on HIV/AIDS

被引:0
作者
Kjell Hausken
Mthuli Ncube
机构
[1] University of Stavanger,Faculty of Social Sciences
[2] St Antony’s College,Blavatnik School of Government & Fellow
[3] University of Oxford,undefined
[4] Radcliffe Observatory Quarter,undefined
来源
Health Economics Review | / 7卷
关键词
Disease; Policy; Game; Funding; Prevention; Treatment; Resource distribution; Free riding; Risky behavior; C72; D72; D74; I10; H51;
D O I
暂无
中图分类号
学科分类号
摘要
A four-period game is developed between a policy maker, the international community, and the population. This research supplements, through implementing strategic interaction, earlier research analyzing "one player at a time". The first two players distribute funds between preventing and treating diseases. The population reacts by degree of risky behavior which may cause no disease, disease contraction, recovery, sickness/death. More funds to prevention implies less disease contraction but higher death rate given disease contraction. The cost effectiveness of treatment relative to prevention, country specific conditions, and how the international community converts funds compared with the policy maker in a country, are illustrated. We determine which factors impact funding, e.g. large probabilities of disease contraction, and death given contraction, and if the recovery utility and utility of remaining sick or dying are far below the no disease utility. We also delineate how the policy maker and international community may free ride on each other’s contributions. The model is tested against empirical data for 43 African countries. The results show consistency between the theoretical model and empirical estimates. The paper argues for the need to create commitment mechanisms to ensure that free riding by both countries and the international community is avoided.
引用
收藏
相关论文
共 50 条
[41]   Kenya AIDS Indicator Surveys 2007 and 2012: Implications for Public Health Policies for HIV Prevention and Treatment [J].
Maina, William K. ;
Kim, Andrea A. ;
Rutherford, George W. ;
Harper, Malayah ;
K'Oyugi, Boniface O. ;
Sharif, Shahnaaz ;
Kichamu, George ;
Muraguri, Nicholas M. ;
Akhwale, Willis ;
De Cock, Kevin M. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 :S130-S137
[42]   Risk behavior and access to HIV/AIDS prevention services in a community sample of homeless persons entering permanent supportive housing [J].
Wenzel, Suzanne L. ;
Rhoades, Harmony ;
Harris, Taylor ;
Winetrobe, Hailey ;
Rice, Eric ;
Henwood, Ben .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2017, 29 (05) :570-574
[43]   Utilization of a population health survey in policy and practice: a case study [J].
Rachel Laws ;
Lesley King ;
Louise L Hardy ;
Andrew Milat ;
Chris Rissel ;
Robyn Newson ;
Lucie Rychetnik ;
Adrian E Bauman .
Health Research Policy and Systems, 11
[44]   Utilization of a population health survey in policy and practice: a case study [J].
Laws, Rachel ;
King, Lesley ;
Hardy, Louise L. ;
Milat, Andrew ;
Rissel, Chris ;
Newson, Robyn ;
Rychetnik, Lucie ;
Bauman, Adrian E. .
HEALTH RESEARCH POLICY AND SYSTEMS, 2013, 11
[45]   People don?t live on the care cascade: The life of the HIV care cascade as an international AIDS policy and its implications [J].
Seckinelgin, Hakan .
GLOBAL PUBLIC HEALTH, 2020, 15 (03) :321-333
[46]   The case for prevention - Primary HIV prevention in the era of universal test and treat: A mathematical modeling study [J].
Kripke, Katharine ;
Eakle, Robyn ;
Cheng, Alison ;
Rana, Sangeeta ;
Torjesen, Kristine ;
Stover, John .
ECLINICALMEDICINE, 2022, 46
[47]   Impact evaluation of a community-based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE-UP study [J].
van de Vijver, Steven ;
Oti, Samuel Oji ;
Gomez, Gabriela B. ;
Agyemang, Charles ;
Egondi, Thaddaeus ;
van Charante, Eric Moll ;
Brewster, Lizzy M. ;
Hankins, Catherine ;
Tanovic, Zlata ;
Ezeh, Alex ;
Kyobutungi, Catherine ;
Stronks, Karien .
GLOBAL HEALTH ACTION, 2016, 9
[48]   Atazanavir-highlights from the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 17-20 July 2011 [J].
Mikula, Tomasz ;
Stanczak, Wojciech .
HIV & AIDS REVIEW, 2011, 10 (04) :82-86
[49]   Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists [J].
Sherman, Elizabeth M. ;
Agwu, Allison L. ;
Ambrosioni, Juan ;
Behrens, Georg M. N. ;
Chu, Carolyn ;
Collins, Lauren F. ;
Jimenez, Humberto R. ;
Koren, David E. ;
McGorman, Leslie ;
Nguyen, Nancy N. ;
Nicol, Melanie R. ;
Pandit, Neha Sheth ;
Pierre, Natacha ;
Scarsi, Kimberly K. ;
Spinner, Gary F. ;
Tseng, Alice ;
Young, Jeremy D. ;
Badowski, Melissa E. .
PHARMACOTHERAPY, 2024, 44 (07) :494-538
[50]   Dissecting the Role of Donors in Capacity Building for HIV/AIDS Treatment, Care and Support: A Case Study of an Antiretroviral Therapy Programme in Zimbabwe [J].
Magocha, Blessing ;
Molope, Mokgadi ;
Palamuleni, Martin .
JOURNAL OF ASIAN AND AFRICAN STUDIES, 2024,